| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| MousePheno | abnormal pancreatic acinar cell morphology | 1.55e-05 | 41 | 17 | 3 | MP:0009146 | |
| MousePheno | abnormal pancreatic acinus morphology | 1.79e-05 | 43 | 17 | 3 | MP:0009145 | |
| MousePheno | abnormal exocrine pancreas morphology | 4.42e-05 | 58 | 17 | 3 | MP:0005220 | |
| MousePheno | abnormal pancreatic acinar cell zymogen granule morphology | 1.87e-04 | 17 | 17 | 2 | MP:0009160 | |
| MousePheno | impaired passive avoidance behavior | 7.63e-04 | 34 | 17 | 2 | MP:0004000 | |
| MousePheno | impaired smooth muscle contractility | 8.09e-04 | 35 | 17 | 2 | MP:0000740 | |
| MousePheno | abnormal gland physiology | 1.09e-03 | 691 | 17 | 5 | MP:0002164 | |
| MousePheno | impaired avoidance learning behavior | 1.16e-03 | 42 | 17 | 2 | MP:0012312 | |
| MousePheno | increased eosinophil cell number | 1.21e-03 | 178 | 17 | 3 | MP:0005011 | |
| Domain | - | 6.04e-03 | 95 | 23 | 2 | 2.60.120.200 | |
| Domain | - | 7.88e-03 | 109 | 23 | 2 | 4.10.280.10 | |
| Domain | HLH | 8.16e-03 | 111 | 23 | 2 | PF00010 | |
| Domain | HLH | 8.89e-03 | 116 | 23 | 2 | SM00353 | |
| Domain | BHLH | 9.03e-03 | 117 | 23 | 2 | PS50888 | |
| Domain | bHLH_dom | 9.18e-03 | 118 | 23 | 2 | IPR011598 | |
| Domain | - | 1.71e-02 | 449 | 23 | 3 | 3.30.40.10 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 1.95e-05 | 42 | 18 | 3 | M7169 | |
| Pathway | WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM | 4.90e-05 | 57 | 18 | 3 | M48326 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 6.62e-05 | 63 | 18 | 3 | M11187 | |
| Pathway | KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG | 4.54e-04 | 25 | 18 | 2 | M18312 | |
| Pathway | REACTOME_RET_SIGNALING | 1.05e-03 | 38 | 18 | 2 | MM15493 | |
| Pathway | REACTOME_RET_SIGNALING | 1.17e-03 | 40 | 18 | 2 | M27746 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 1.59e-03 | 186 | 18 | 3 | MM15994 | |
| Pubmed | 1.78e-05 | 9 | 25 | 2 | 10331972 | ||
| Pubmed | 2.22e-05 | 10 | 25 | 2 | 11069590 | ||
| Pubmed | Differential RET signaling pathways drive development of the enteric lymphoid and nervous systems. | 3.85e-05 | 13 | 25 | 2 | 22855506 | |
| Pubmed | 7.54e-05 | 18 | 25 | 2 | 12921743 | ||
| Pubmed | 8.42e-05 | 19 | 25 | 2 | 19022256 | ||
| Pubmed | Generation of a Conditional Allele of the Transcription Factor Atonal Homolog 8 (Atoh8). | 9.35e-05 | 20 | 25 | 2 | 26752640 | |
| Pubmed | 1.36e-04 | 24 | 25 | 2 | 22529374 | ||
| Pubmed | Hippo signaling regulates pancreas development through inactivation of Yap. | 1.60e-04 | 26 | 25 | 2 | 23071096 | |
| Pubmed | 1.99e-04 | 29 | 25 | 2 | 33527355 | ||
| Pubmed | 2.28e-04 | 31 | 25 | 2 | 22178591 | ||
| Pubmed | 2.74e-04 | 34 | 25 | 2 | 26771085 | ||
| Pubmed | 3.08e-04 | 36 | 25 | 2 | 25063451 | ||
| Pubmed | 5.04e-04 | 46 | 25 | 2 | 23684747 | ||
| GeneFamily | Basic helix-loop-helix proteins | 5.27e-03 | 110 | 18 | 2 | 420 | |
| Coexpression | GSE17721_0.5H_VS_12H_CPG_BMDC_DN | 3.60e-05 | 199 | 25 | 4 | M4122 | |
| Coexpression | GSE22935_WT_VS_MYD88_KO_MACROPHAGE_12H_MBOVIS_BCG_STIM_DN | 3.67e-05 | 200 | 25 | 4 | M7751 | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Six3-Inhibitory_Neuron.Gad1Gad2.Six3-Sst_(Reticular_formation)-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.26e-05 | 81 | 25 | 3 | e58f07266b7bad0af9a9856c678b4e0850c9f6c9 | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Six3-Inhibitory_Neuron.Gad1Gad2.Six3-Sst_(Reticular_formation)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.26e-05 | 81 | 25 | 3 | 717751c7a6af08cec7d0e561869e4b292d1f83a5 | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Six3|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.30e-05 | 82 | 25 | 3 | 47b131333ab84b70d2abe3fc17e63de504214b1b | |
| Drug | Dipyridamole [58-32-2]; Up 200; 8uM; MCF7; HT_HG-U133A | 5.73e-05 | 195 | 25 | 4 | 1517_UP | |
| Drug | 3-nitropropionic acid; Down 200; 10uM; MCF7; HT_HG-U133A | 5.85e-05 | 196 | 25 | 4 | 6402_DN | |
| Drug | Sulindac [38194-50-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 5.85e-05 | 196 | 25 | 4 | 5528_DN | |
| Drug | Benfotiamine [22457-89-2]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 5.96e-05 | 197 | 25 | 4 | 3837_DN | |
| Drug | Myosmine [532-12-7]; Up 200; 27.4uM; PC3; HT_HG-U133A | 6.08e-05 | 198 | 25 | 4 | 4293_UP | |
| Drug | Gliquidone [33342-05-1]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 6.20e-05 | 199 | 25 | 4 | 6004_DN | |
| Drug | Bendroflumethiazide [73-48-3]; Up 200; 9.4uM; HL60; HT_HG-U133A | 6.20e-05 | 199 | 25 | 4 | 2555_UP | |
| Drug | Lomefloxacin hydrochloride [98079-52-8]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 6.20e-05 | 199 | 25 | 4 | 2310_DN | |
| Disease | hippocampal CA1 volume | 6.41e-04 | 48 | 23 | 2 | EFO_0009394 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QRRIRLLSRGPCGSR | 231 | O00468 | |
| ARAAARAPGEGRRRR | 46 | Q7RTS1 | |
| RILGCQCRGRGRRRR | 361 | P35368 | |
| GRRRRRRRRRLGGCA | 371 | P35368 | |
| AACFRRRRLARRPGY | 31 | Q9NRI5 | |
| RGPGAGARRRRTRCR | 26 | Q6PCT2 | |
| GPSGRRPSARCARRR | 26 | Q9HCM3 | |
| RPSARCARRRRPGLL | 31 | Q9HCM3 | |
| RAGPRRRRARARLGA | 86 | Q99748 | |
| RRRARARLGARPCGL | 91 | Q99748 | |
| RRLGRRARCHGPGRA | 31 | Q9NQR1 | |
| EGGCRGAPRKLRARR | 51 | Q9Y4Z2 | |
| LARYGAARCGRLRRR | 191 | Q96KK3 | |
| LARARGCPRGPRLLR | 671 | A6NGR9 | |
| ALGCGLAERPRRARR | 16 | Q13219 | |
| RGRRRPGRFVRLVAA | 236 | Q9Y5Y4 | |
| PLRARALRGRRLALG | 181 | Q96RI0 | |
| RRGDEARGAPCRRRR | 261 | C9JJ37 | |
| ARGAPCRRRRGTLPR | 266 | C9JJ37 | |
| RGLRSRASRCRPRSL | 311 | Q15884 | |
| QGGCPRARCRRALRR | 56 | Q9GZZ7 | |
| PGAAARCLRKGRRRL | 311 | Q9NWQ4 | |
| PRAAARRRRRGARAA | 126 | Q8N9Z2 | |
| RRRARSRRAPAPGAL | 51 | O00198 | |
| RDRQRLRFGPRRALA | 131 | Q92737 | |
| DPKCRSGGRRRRLTL | 21 | Q6ZMZ0 | |
| GLLRHRGLRPRCCRR | 306 | Q6ZMH5 | |
| RDCRCRRPRRWPRAG | 141 | Q9H7T3 | |
| RRRLRRRPRGLRCSR | 16 | Q9ULT6 | |
| RSPAVARRCGRPRRR | 81 | Q96NR7 |